◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
凯赛生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 3.0B 2.1B 2.4B 2.4B 1.5B
Revenue Growth % 39.9% -13.4% 3.3% 57.8% --
Total Revenue 3.0B 2.1B 2.4B 2.4B 1.5B
Cost Of Revenue 2.0B 1.5B 1.6B 1.5B 799.0M
+Gross Profit 924.0M 609.0M 860.0M 842.0M 698.0M
Gross Margin % 31.2% 28.8% 35.2% 35.6% 46.6%
Total Operating Cost 2.5B 1.8B 1.8B 1.7B 1.0B
Selling Expenses 54.6M 38.2M 45.1M 41.8M 24.0M
Admin Expenses 168.0M 184.0M 189.0M 134.0M 120.0M
Rd Expenses 233.0M 189.0M 188.0M 134.0M 84.3M
Finance Expenses -164.0M -211.0M -295.0M -182.0M -10.9M
+Operating Income 552.0M 454.0M 708.0M 723.0M 522.0M
Operating Margin % 18.7% 21.5% 29.0% 30.6% 34.9%
Non Operating Income 1.0M 1.8M 5.1M 1.3M 709,400
Non Operating Expenses 4.6M 7.2M 17.4M 173,600 2.2M
Investment Income -9.0M -7.8M -3.7M 16.3M 18.8M
Fair Value Change Income -- -- -- -- 9.2M
Asset Disposal Income 403,300 -5,800 46,800 -- --
Asset Impairment Loss 87.3M 29.0M 29.5M 4.3M 8.5M
Other Income 54.1M 104.0M 39.2M 25.5M 40.5M
Income Before Tax 548.0M 449.0M 696.0M 724.0M 521.0M
Income Tax 73.4M 40.4M 83.3M 90.9M 63.4M
+Net Income 475.0M 409.0M 613.0M 634.0M 457.0M
Net Margin % 16.1% 19.3% 25.1% 26.8% 30.5%
Net Income Attributable 489.0M 367.0M 553.0M 595.0M 458.0M
Minority Interest -14.4M 42.0M 59.4M 38.8M -331,100
Eps Basic 0.84 0.63 0.95 1.02 1.18
Eps Diluted 0.84 0.63 0.95 1.02 1.18
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 5.3B 5.4B 6.3B 9.6B 5.7B
Trading Financial Assets 469,200 469,200 469,200 469,200 1.3B
Accounts Receivable 247.0M 243.0M 390.0M 259.0M 188.0M
Notes Receivable 101.0M 62.9M 48.6M 11.4M 5.8M
Notes And Accounts Receivable 348.0M 306.0M 439.0M 271.0M 194.0M
Prepayments 65.6M 30.5M 50.5M 66.8M 29.2M
Inventory 1.2B 1.5B 1.6B 1.2B 775.0M
Total Current Assets 7.4B 7.6B 8.5B 11.4B 8.4B
Long Term Equity Investment 134.0M 143.0M 49.5M 53.2M 56.2M
Fixed Assets -- 3.9B 3.5B 2.2B 1.2B
Fixed Assets Total 3.9B 3.9B 3.5B 2.2B 1.2B
Construction In Progress -- 5.4B 3.1B 758.0M 1.6B
Construction In Progress Total 5.9B 5.4B 3.2B 758.0M 1.6B
Intangible Assets 685.0M 704.0M 778.0M 768.0M 228.0M
Long Term Deferred Expenses 6.4M 5.0M 7.2M 9.6M 7.9M
Total Non Current Assets 11.6B 11.3B 9.4B 4.8B 3.7B
Total Assets 19.0B 18.8B 17.8B 16.2B 12.1B
Short Term Borrowings 1.2B 746.0M 161.0M 744.0M --
Accounts Payable 1.4B 1.7B 1.1B 290.0M 353.0M
Advance Receipts 2.5M 2.5M -- -- --
Contract Liabilities 35.8M 10.5M 17.8M 14.6M 19.9M
Total Current Liabilities 2.9B 3.4B 1.4B 1.2B 435.0M
Long Term Borrowings 613.0M 245.0M 961.0M -- --
Total Non Current Liabilities 1.0B 651.0M 1.4B 293.0M 216.0M
Total Liabilities 3.9B 4.1B 2.8B 1.5B 651.0M
Paid In Capital 583.0M 583.0M 583.0M 417.0M 417.0M
Capital Reserve 8.5B 8.5B 8.5B 8.7B 8.7B
Surplus Reserve 239.0M 98.4M 98.0M 92.1M 83.0M
Retained Earnings 2.3B 2.1B 1.8B 1.4B 1.2B
Minority Equity 3.6B 3.6B 4.1B 4.0B 1.1B
Equity Attributable 11.5B 11.2B 10.9B 10.7B 10.4B
Total Equity 15.1B 14.8B 15.0B 14.7B 11.5B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 2.9B 2.1B 2.2B 2.2B 1.4B
Tax Refunds Received 60.2M 111.0M 465.0M 132.0M 63.5M
Total Operating Cash Inflow 3.4B 2.6B 3.4B 2.6B 1.6B
Cash Paid For Goods 1.7B 1.3B 1.8B 1.5B 637.0M
Cash Paid To Employees 257.0M 272.0M 279.0M 213.0M 154.0M
Taxes Paid 289.0M 202.0M 183.0M 119.0M 99.5M
Total Operating Cash Outflow 2.5B 2.1B 2.5B 2.0B 1.0B
Operating Cash Flow 821.0M 569.0M 804.0M 579.0M 515.0M
Total Investing Cash Inflow 20.3M 142.0M 140,400 3.2B 5.4B
Total Investing Cash Outflow 843.0M 1.7B 4.2B 3.3B 6.6B
Investing Cash Flow -823.0M -1.6B -4.2B -111.0M -1.2B
Cash From Borrowings 1.7B 937.0M 1.1B 798.0M --
Dividends And Interest Paid 141.0M 138.0M 207.0M 340.0M 3.9M
Debt Repayments 1.6B 290.0M 740.0M 55.0M 300.0M
Total Financing Cash Inflow 1.9B 941.0M 1.4B 3.7B 6.7B
Total Financing Cash Outflow 1.7B 1.2B 1.0B 695.0M 597.0M
Financing Cash Flow 149.0M -262.0M 404.0M 3.0B 6.1B
Net Change In Cash 172.0M -1.2B -2.9B 3.4B 5.4B
Ending Cash Balance 5.2B 5.0B 6.2B 9.2B 5.7B
Capex 843.0M 1.6B 4.2B 1.5B 763.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...